2019 Conference Agenda

Stanford University

Frances C. Arrillaga Alumni Center – McCaw Hall

326 Galvez Street
Stanford, CA 94305-6105

Download the 2019 Conference Agenda

September 24-26, 2019

Tuesday, September 24, 2019

08:00 – 09:00

Registration & Light Breakfast – Frances C. Arrillaga Alumni Center – McCaw Hall

09:00 – 09:15

Welcome from Leadership

09:15 – 11:50

Integrative Early Detection through Multiple Technologies

Session Chairs: Gordon Mills, MD, PhD (OHSU) and Tony Ng, MD, PhD (King’s College London)

Tony Ng, MD, PhD – Kings College London
Victor Velculescu, MD, PhD – Johns Hopkins University
Stephen Gould, PhD – Johns Hopkins University
Jason Locasale, PhD – Duke University, School of Medicine

11:50 – 12:20

Poster Lightning Talks

12:20 – 14:20

Lunch Break & Poster Viewing

14:20 – 16:55

Prognostic Early Detection: How Can We Differentiate Indolent from Progressive Cancers when Looking at Early or Pre-Cancerous Lesions in Different Tissues

Session Chairs: Denise Aberle, MD (UCLA) and Tanya Stoyanova, PhD (Canary Center at Stanford)

James Brooks, MD – Stanford University
Daniel Lin, MD – University of Washington
Jelle Wesseling, MD, PhD – Netherlands Cancer Institute
Sam Janes, MD, PhD – University College London

17:00 – 19:00

Reception / Networking  – Frances C. Arrillaga Alumni Center – McCaw Hall

Wednesday, September 25, 2019

08:30 – 09:00

Light Breakfast – Frances C. Arrillaga Alumni Center – McCaw Hall

09:00 – 09:05

Welcome & Recap

09:05 – 11:40

Signals from Beyond the Tumor: Role of Tumor Microenvironment and Immune System in Early Cancer Detection

Session Chairs: Mark Davis, PhD (Stanford University) and Amanda Lund, PhD (OHSU)

Jennifer Wargo, MD, MMSc – MD Anderson Cancer Center
Garry Nolan, PhD – Stanford University
Sheila Stewart, PhD – Washington University
Mark Davis, PhD – Stanford University

11:40 – 12:00

Poster Lightning Talks

12:00 – 13:50

Lunch Break & Poster Viewing

13:50 – 14:20

Late Breaking Results: TRACERx Study

  • Charles Swanton, MD, PhD – The Francis Crick Institute

14:20 – 16:55

Integrative Susceptibility for Early Detection: How Can We Go Beyond Traditional Risk Factors, Integrating Across Measures, to Better Select Populations at Higher Risk of Cancer?

Session Chairs: Antonis Antoniou, PhD (University of Cambridge) and James Ford, MD (Stanford University)

Allison Kurian, MD, MSc – Stanford University
Paul Pharoah, MD, PhD – University of Cambridge
Gerrit Meijer, MD, PhD – Netherlands Cancer Institute
Suzette Delaloge, MD, MSc – Gustave Roussy Institute

17:30 – 21:00

Dinner Reception – Stanford Stadium

Thursday, September 26, 2019

08:30 – 09:00

Light Breakfast – Frances C. Arrillaga Alumni Center – McCaw Hall

09:00 – 09:05

Welcome & Recap

09:05 – 09:45

Special Presentation:  Artificial Intelligence / Machine Learning Challenges and Opportunities for Early Detection

  • Jim Brase, M.S. – Lawrence Livermore National Laboratory

09:45 – 12:20

Fostering a Translational Mentality in Early Detection Research

Session Chairs: Ruth Etzioni, PhD (Fred Hutchinson Cancer Research Center) and George Hanna, PhD (Imperial College London)

Philip Castle, PhD – Albert Einstein College of Medicine
Douglas Owens, MD – Stanford University
Fiona Walter, MD – University of Cambridge
Julie Barnes, PhD – Abcodia

(Session will have a short break between 10.20 – 10.40)

12:20 – 12:35

Poster Lightning Talks

12:35 – 14:00

Lunch Break & Poster Viewing

14:00 – 15:30

Final Discussion

Sharon Pitteri, PhD – Canary Center at Stanford
Ashok Venkitaraman, MD, PhD – University of Cambridge
Bree Mitchell, PhD – Oregon Health and Science University

The purpose of the session is to:

  • Explore the challenges and barriers to progress which have emerged over the course of the conference
  • Identify where gaps exist in our knowledge and expertise
  • Define these roadblocks as tractable challenges and as calls-to-action for the whole cancer research community
  • Explore how these challenges might be addressed through collaboration and integration of ideas from multiple disciplines, research areas and sectors
  • Consider the above with a mind-set of achieving meaningful progress towards impact on health
  • Provide input which will influence funders’ thinking around how they should develop and implement funding strategy in this field


Meeting Close